一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 11 月 12 日 证券代码：605009 证券简称：豪悦护理 公告编号：2025-057 杭州豪悦护理用品股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 (二)股东大会召开的地点：浙江省杭州市临平区东湖街道临平经济技术开发区红 丰路 655 号 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 207 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 145,285,666 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 67.5534 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 是 (五)公司董事、监事和董事会秘书的出席情况 1、公司在任董事7人，出席6人，朱威莉因公出差未能出席本次股东 ...

国浩律师（杭州）事务所 关于 杭州豪悦护理用品股份有限公司 2025 年第二次临时股东大会 法律意见书 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二五年十一月 国浩律师（杭州）事务所 法律意见书 国浩律师（杭州）事务所 关于杭州豪悦护理用品股份有限公司 2025 年第二次临时股东大会 法律意见书 致：杭州豪悦护理用品股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受杭州豪悦护理用品股份 有限公司（以下简称"公司"）委托，指派律师出席公司 2025 年第二次临时股东 大会（以下简称"本次 ...

Market Overview - The personal care products sector increased by 0.79% on November 12, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 9.97, up 12.15% with a trading volume of 328,200 shares and a turnover of 319 million yuan [1] - Reliable Co., Ltd. (301009) closed at 14.82, up 6.39% with a trading volume of 206,500 shares and a turnover of 302 million yuan [1] - Two-sided Needle (600249) closed at 7.00, up 3.09% with a trading volume of 456,100 shares and a turnover of 320 million yuan [1] - Other notable performances include Yiyi Co., Ltd. (001206) up 2.72% and Zhongshun Jiesang (002511) up 0.96% [1] Capital Flow - The personal care products sector saw a net inflow of 115 million yuan from institutional investors, while retail investors experienced a net outflow of 110 million yuan [2] - The sector's main stocks showed varied capital flows, with Reliable Co., Ltd. receiving a net inflow of 50.84 million yuan from institutional investors [3] - Yanjiang Co., Ltd. had a net inflow of 22.24 million yuan, while Yiyi Co., Ltd. saw a net inflow of 17.75 million yuan [3]

Group 1 - The core viewpoint of the articles indicates a significant rebound in the consumer sector, with various sub-sectors such as beauty care, food and beverage, retail, and tourism showing strong stock performance as of November 10, 2023 [1][2] - The Shanghai Composite Index closed with a gain of 0.53%, surpassing the 4000-point mark, driven by a collective surge in consumer stocks [1] - The Ministry of Finance's report on November 7, 2023, highlighted ongoing efforts to boost consumption through fiscal policies, including subsidies for personal consumption loans [1][2] Group 2 - The food and beverage sector is nearing a bottom in its fundamental performance, with expectations for recovery increasing as negative impacts have largely been released [2] - The service consumption sector is undergoing a transformation, supported by policy initiatives, and is expected to become a key investment focus [2] - The "14th Five-Year Plan" emphasizes the importance of enhancing consumer power and expanding the supply of quality consumer goods and services [2] Group 3 - A total of 123 consumer stocks with rolling P/E ratios below 30 and underperforming the Shanghai Composite Index have been identified, indicating potential valuation advantages [3] - Among these, nine stocks with market capitalizations exceeding 100 billion yuan include major players like Kweichow Moutai and Gree Electric [3] - The stock with the largest decline is Ganyuan Food, which has dropped 33.79% year-to-date, with a reported net profit decline of 43.66% in the first three quarters [3][4] Group 4 - There are 43 stocks among the identified consumer stocks that have an upside potential exceeding 20%, with Poya leading at 49.05% [6][8] - Xueda Education and Haoyue Care follow closely with expected increases of 48.6% and 47.01%, respectively, driven by their strong market positions and growth strategies [6][7] - Poya has submitted a prospectus for a Hong Kong IPO to accelerate international expansion and support potential mergers and acquisitions [6][8]

Market Overview - The personal care products sector increased by 3.74% on November 10, with Yiyi Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] Stock Performance - Yiyi Co., Ltd. (001206) closed at 31.47, up 10.00% with a trading volume of 100,400 shares and a transaction value of 306 million [1] - Other notable performers include: - Stable Medical (300888) at 43.30, up 5.61% [1] - Dengkang Oral (001328) at 37.90, up 4.04% [1] - Reliable Co., Ltd. (301009) at 13.88, up 3.27% [1] - HaoYue Nursing (6009509) at 33.33, up 2.87% [1] Capital Flow - The personal care products sector saw a net inflow of 113 million from main funds, while retail investors experienced a net outflow of approximately 99.87 million [2][3] - Main fund inflows were led by Yiyi Co., Ltd. with 55.37 million, accounting for 18.09% of the total [3] - Stable Medical had a main fund inflow of 39.87 million, representing 6.43% of the total [3] Individual Stock Capital Flow - Reliable Co., Ltd. had a main fund inflow of 9.37 million, with retail investors showing a net outflow of 2.44 million [3] - Other stocks with significant capital flow include: - Dengkang Oral with a main fund inflow of 1.54 million and a retail outflow of 470,980 [3] - Baiya Co., Ltd. (003006) with a main fund inflow of 6.94 million and a retail outflow of 2.32 million [3]

Core Viewpoint - The stock of Haoyue Nursing has shown fluctuations with a year-to-date increase of 18.05%, but has experienced a significant decline of 19.38% over the past 60 days, indicating volatility in its performance [1][2]. Financial Performance - For the period from January to September 2025, Haoyue Nursing achieved a revenue of 2.718 billion yuan, representing a year-on-year growth of 33.18%. However, the net profit attributable to shareholders decreased by 30.94% to 203 million yuan [2]. - The company has distributed a total of 979 million yuan in dividends since its A-share listing, with 717 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 10, Haoyue Nursing's stock price was 33.07 yuan per share, with a market capitalization of 7.112 billion yuan. The stock has seen a trading volume of 39.2596 million yuan and a turnover rate of 0.56% [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on September 1, where it recorded a net buy of -46.1651 million yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Haoyue Nursing increased by 33.50% to 23,400, while the average circulating shares per person decreased by 25.24% to 9,184 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fifth largest, holding 2.0901 million shares, a decrease of 2.5255 million shares from the previous period [3].

Market Overview - The personal care products sector increased by 0.76% on November 7, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 9.15, up 2.35% with a trading volume of 122,400 shares and a turnover of 112 million yuan [1] - Beijia Clean (603059) closed at 31.80, up 2.09% with a trading volume of 31,500 shares and a turnover of 99.4 million yuan [1] - Stable Medical (300888) closed at 41.00, up 1.91% with a trading volume of 77,500 shares and a turnover of 318 million yuan [1] - Other notable stocks include Jeya Co., Ltd. (301108) up 0.91% and Baiya Co., Ltd. (003006) up 0.58% [1] Fund Flow Analysis - The personal care products sector experienced a net outflow of 12.73 million yuan from institutional investors, while retail investors saw a net inflow of 5.30 million yuan [2] - The overall fund flow indicates a mixed sentiment, with institutional investors pulling back while retail investors showed interest [2] Individual Stock Fund Flow - Yiyi Co., Ltd. (001206) had a net inflow of 9.33 million yuan from institutional investors but a net outflow of 18.01 million yuan from retail investors [3] - Yanjiang Co., Ltd. (300658) saw a net inflow of 5.49 million yuan from institutional investors but a net outflow of 7.83 million yuan from retail investors [3] - Stable Medical (300888) had a net inflow of 2.14 million yuan from institutional investors and a net outflow of 15.55 million yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a decline of 0.3% on November 6, with Runben Co., Ltd. leading the drop. Meanwhile, the Shanghai Composite Index rose by 0.97% to close at 4007.76, and the Shenzhen Component Index increased by 1.73% to 13452.42 [1]. Group 1: Market Performance - The personal care products sector saw a mixed performance among individual stocks, with notable gainers including Beijiajie (+1.53%) and Liangmianjin (+1.08%), while Runben Co., Ltd. led the decline at -1.86% [1][2]. - The trading volume for Beijiajie was 21,300 hands, with a transaction value of approximately 65.74 million yuan, while Runben Co., Ltd. had a trading volume of 41,700 hands and a transaction value of about 108 million yuan [1][2]. Group 2: Capital Flow - The personal care products sector experienced a net outflow of 23.85 million yuan from institutional investors, while retail investors saw a net inflow of 15.48 million yuan [2]. - Among individual stocks, Liangmianjin attracted a net inflow of 11.18 million yuan from institutional investors, while Runben Co., Ltd. faced a net outflow of 1.36 million yuan [3].

Core Insights - On November 4, 67 target price adjustments were made by brokerages for listed companies, with notable increases in target prices for Aibo Medical, Lingyun Co., and Haoyue Nursing, showing increases of 70.94%, 54.33%, and 51.42% respectively, across the medical device, automotive parts, and personal care industries [1][2]. Target Price Increases - Aibo Medical (688050) received a target price of 108.41 yuan with a target increase of 70.94% from Nomura Orient International Securities [2] - Lingyun Co. (600480) has a target price of 19.60 yuan with a target increase of 54.33% from Huachuang Securities [2] - Haoyue Nursing (605009) was assigned a target price of 49.00 yuan with a target increase of 51.42% from China International Capital Corporation [2] - Other companies with significant target price increases include Weichuang Electric (688698) at 46.90%, Bull Group (603195) at 46.72%, and Wuxi Zhenhua (605319) at 46.41% [2]. Brokerage Recommendations - On November 4, four companies had their ratings upgraded, including: - Jiantou Energy (000600) upgraded from "Hold" to "Buy" by Shanxi Securities [4] - Senxuan Pharmaceutical (920946) upgraded from "Hold" to "Increase" by Jianghai Securities [4] - China National Glass (600176) upgraded from "Increase" to "Buy" by Western Securities [4] - Suochen Technology (688507) upgraded from "Increase" to "Buy" by Industrial Securities [4] Rating Downgrades - Two companies had their ratings downgraded on November 4: - Rongsheng Petrochemical (002493) downgraded from "Strong Buy" to "Buy" by Founder Securities [5] - Proya Cosmetics (603605) downgraded from "Buy" to "Increase" by Jianghai Securities [5] First-Time Coverage - Four companies received initial coverage on November 4: - Zhonglv Electric (000537) rated "Buy" by Guotou Securities [7] - Chaohongji (002345) rated "Recommended" by Ping An Securities [7] - Dongmu Co. (600114) rated "Increase" by Hualong Securities [7] - Haomei New Materials (002988) rated "Increase" by Northeast Securities [7]

Summary of Key Points Core Viewpoint - On November 4, a total of 67 target price adjustments were made by brokerages for listed companies, with notable increases in target prices for Aibo Medical, Lingyun Co., and Haoyue Care, reflecting significant growth potential in the medical device, automotive parts, and personal care industries respectively [1][2]. Group 1: Target Price Increases - Aibo Medical (688050) received a target price increase of 70.94%, with a new target price of 108.41 yuan, rated as "Buy" by Nomura Orient International Securities [2]. - Lingyun Co. (600480) saw a target price increase of 54.33%, with a new target price of 19.60 yuan, rated as "Strong Buy" by Huachuang Securities [2]. - Haoyue Care (605009) had a target price increase of 51.42%, with a new target price of 49.00 yuan, rated as "Outperform" by China International Capital Corporation [2]. Group 2: Brokerage Recommendations - A total of 199 listed companies received brokerage recommendations on November 4, with notable mentions including Conch Cement (600585), Wuliangye (000858), Shanxi Fenjiu (600809), and Northern Huachuang (002371), each receiving three recommendations [3][4]. - Conch Cement (600585) closed at 23.01 yuan and was recommended by three brokerages in the cement industry [4]. - Wuliangye (000858) closed at 117.16 yuan and was also recommended by three brokerages in the liquor industry [4]. Group 3: Rating Adjustments - Four companies had their ratings upgraded on November 4, including Jiantou Energy (000600), which was upgraded from "Hold" to "Buy" by Shanxi Securities [5]. - Other companies with upgraded ratings include Senxuan Pharmaceutical (920946) and China National Glass (600176), reflecting positive sentiment from brokerages [5]. - Two companies had their ratings downgraded, including Rongsheng Petrochemical (002493) and Proya Cosmetics (603605), indicating a shift in market perception [6]. Group 4: First Coverage - Four companies received initial coverage on November 4, including Zhonglv Electric (000537) rated "Buy" by Guotou Securities, and Chaohongji (002345) rated "Recommended" by Ping An Securities [8]. - Other companies receiving first coverage include Dongmu Co. (600114) and Haomei New Materials (002988), indicating new investment opportunities in their respective sectors [8].